Genetic Testing Market Outlook 2018

  • October 2014
  • -
  • RNCOS
  • -
  • 120 pages

A recent report, “Genetic Testing Market Outlook 2018”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in this report. On account of our analysis of the past and present market trends; drivers; and existing strengths and challenges; forecast for genetic testing has been drawn, according to which, the market is likely to grow at a CAGR of around 9% during 2013-2018.

Our report is an outcome of extensive interaction with industry experts which has led us to portray the updated status of genetic testing in various therapeutic areas, major geographies and significant industry applications. The genetic testing industry has seen several new product launches, active research innovations, strategic activities, launch of new DTC tests, and wider therapeutic applications.

The report effectively illustrates the role of genetic testing in diseases such as Cancer, Cystic Fibrosis, and Alzheimer. It also incorporates the information on disease prevalence, available tests, and genes that cause a particular disease. An extensive research and reliable statistics in terms of market size, developments and future performance for emerging sectors namely, Next-Generation Sequencing, Whole Genome Sequencing, Non Invasive Prenatal Diagnostics, and Personalized Medicine have been covered in the report.

Genetic testing is growing in both developing and developed nations with both industry and research personnel highlighting the significance of molecular biology. The report provides comprehensive analytics of key developments for major markets including the U.S., Europe and Asian countries, and their market overview. Country level analysis depicts the level of penetration for genetic testing, types of tests available, consumer perspectives, regulatory stringency and future growth.

The report also profiles the ten most active genetic testing market players worldwide: Abbott Laboratories, Roche Diagnostics, Myriad Genetics, Life Technologies, Agilent, Hologic, Illumina, Qiagen, Cepheid, and Affymetrix.

Table Of Contents

1. Analyst View
2. Research Methodology
3. Genetic Testing Overview
3.1 Application and Advantages
3.2 Methods
4. Global Genetic Testing Market Overview
4.1 Market Outlook
4.2 Genetic Testing Laboratories - Unmet Need Analysis
4.3 Direct-to-Consumer (DTC) Genetic Testing
5. Disease-Wise Analysis
5.1 Alzheimer's Disease
5.2 Cystic Fibrosis
5.3 Cancer
6. Country-Level Analysis
6.1 US
6.1.1 Market Overview
6.1.2 Recent Developments
6.2 Europe
6.2.1 Market Overview
6.2.2 Recent Developments
6.3 Asia
6.3.1 Market Overview
6.3.2 Recent Developments
7. Emerging Sectors
7.1 Next-Generation Sequencing (NGS)
7.2 Non-Invasive Prenatal Testing (NIPT)
7.3 Whole Genome Sequencing (WGS) for Cancer
7.4 Personalized Medicine
8. Genetic Testing Regulation
9. Competitive Assessment
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Product Offering
9.1.3 Key Financials
9.1.4 Recent Developments
9.1.5 Strengths and Weaknesses
9.2 Roche Diagnostics
9.2.1 Company Overview
9.2.2 Product Offering
9.2.3 Key Financials
9.2.4 Recent Developments
9.2.5 Strengths and Weaknesses
9.3 Myriad Genetics, Inc.
9.3.1 Company Overview
9.3.2 Product Offering
9.3.3 Key Financials
9.3.4 Recent Developments
9.3.5 Strengths and Weaknesses
9.4 Life Technologies Corporation (Thermo Fisher Scientific)
9.4.1 Company Overview
9.4.2 Product Offering
9.4.3 Key Financials
9.4.4 Recent Developments
9.4.5 Strengths and Weaknesses
9.5 Agilent Technologies Inc.
9.5.1 Company Overview
9.5.2 Product Offering
9.5.3 Key Financials
9.5.4 Recent Development
9.5.5 Strengths and Weaknesses
9.6 Hologic, Inc.
9.6.1 Company Overview
9.6.2 Product Offering
9.6.3 Key Financials
9.6.4 Recent Developments
9.6.5 Strengths and Weaknesses
9.7 Illumina, Inc.
9.7.1 Company Overview
9.7.2 Product Offering
9.7.3 Key Financials
9.7.4 Recent Developments
9.7.5 Strengths and Weaknesses
9.8 Qiagen NV
9.8.1 Company Overview
9.8.2 Products Offering
9.8.3 Key Financials
9.8.4 Recent developments
9.8.5 Strengths and Weaknesses
9.9 Cepheid
9.9.1 Company Overview
9.9.2 Product Offering
9.9.3 Key Financials
9.9.4 Recent developments
9.9.5 Strengths and Weakness
9.10 Affymetrix, Inc.
9.10.1 Company Overview
9.10.2 Product Offering
9.10.3 Key Financials
9.10.4 Recent Developments
9.10.5 Strength and Weakness

List of Figures:

Figure 4-1: Genetic Testing Market (Billion US$), 2013-2018
Figure 4-2: Genetic Testing Market by Geography (%), 2013
Figure 4-3: Number of Companies in Biochemical DTC Genetic Testing Segment (2007-2010)
Figure 4-4: Number of DTC Genetic Testing Companies by Country
Figure 6-1: Number of Disorder, Genes, Labs, and Clinics for Genetic Testing (2013 and 2014)
Figure 6-2: Number of Genetic Tests (2013 and 2014)
Figure 6-3: US - Number of Genetic Tests Available in the Market (2008 and 2012)
Figure 6-4: US - Genetic Testing Equipment Market (Billion US$), 2013-2018
Figure 6-5: Europe - Genetic Testing Equipment Market (Billion US$), 2013-2018
Figure 7-1: Global - Next Generation Sequencing Market (Billion US$), 2013-2018
Figure 7-2: Global - NGS Application by Sector (%)
Figure 7-3: Global - Next Generation Sequencing Market by Player (%), 2012
Figure 7-4: US - Non-Invasive Prenatal Testing Market (Million US$), 2013-2018
Figure 7-5: US - Tapped and Untapped Personalized Cancer WGS Market (%), 2013
Figure 7-6: US - Personalized Cancer WGS Market (Million US$), 2013-2018
Figure 7-7: Organizational Transformation to Support Personalized Medicine
Figure 8-1: Genetic Testing Regulatory Agencies
Figure 9-1: Abbott Laboratories - Revenue Breakup by Geography (%), 2013
Figure 9-2: Abbott Laboratories - Revenue Breakup by Diagnostics Division (%), 2013
Figure 9-3: Roche Holding - Diagnostic Division Revenue by Geography (%), 2013
Figure 9-4: Roche Holding - Revenue Breakup by Business Division (%), 2013
Figure 9-5: Myriad Genetics - Revenue Breakup by Business Segment (%), 2013
Figure 9-6: Life Technologies - Revenue Breakup by Geography (%), 2012
Figure 9-7: Life Technologies - Revenue Breakup by Business Segment (%), 2012
Figure 9-8: Agilent - Revenue Breakup by Business Segment (%), 2013
Figure 9-9: Hologic - Revenue Breakup by Business Segment (%), 2013
Figure 9-10: Hologic - Revenue Breakup by Geography (%), 2013
Figure 9-11: Illumina - Revenue Breakup by Geography (%), 2013
Figure 9-12: Qiagen NV - Revenue Break up by Business Segment (%), 2013
Figure 9-13: Qiagen NV - Revenue Break up by Geography (%), 2013
Figure 9-14: Cepheid - Revenue Break up by Business Segment (%), 2013
Figure 9-15: Cepheid - Revenue Break up by Geography (%), 2013
Figure 9-16: Affymetrix - Revenue Breakup by Geography (%), 2013
Figure 9-17: Affymetrix - Revenue Breakup by Business Segment (%), 2013

List of Tables:

Table 4-1: Key DTC Genetic Testing Companies by Category
Table 4-2: Key Test Areas Offered in DTC Genetic Testing Segment
Table 7-1: FDA Approved Pharmacogenomic Biomarkers for Oncology
Table 9-1: Abbott Laboratories - Key Gene Based Products
Table 9-2: Abbott Laboratories - Financial Performance (Million US$), 2010-2012
Table 9-3: Roche Molecular Diagnostics - Key Gene Based Products
Table 9-4: Roche Holding - Financial Performance (Million CHF), 2011-2013
Table 9-5: Myriad Genetics - Key Gene Based Products
Table 9-6: Myriad Genetics - Financial Performance (Million US$), 2011-2013
Table 9-7: Life Technologies - Key Gene Based Products
Table 9-8: Life Technologies - Financial Performance (Million US$), 2010-2012
Table 9-9: Agilent - Key Gene Based Products
Table 9-10: Agilent - Financial Performance (Million US$), 2011-2013
Table 9-11: Hologic - Key Gene Based Products
Table 9-12: Hologic - Financial Performance (Million US$), 2011-2013
Table 9-13: Illumina - Key Gene Based Products
Table 9-14: Illumina - Financial Performance (Million US$), 2011-2013
Table 9-15: Qiagen NV - Key Gene Based Products
Table 9-16: Qiagen NV - Financial Performance (Million US$), 2011-2013
Table 9-17: Cepherid - Key Gene Based Products
Table 9-18: Cepheid - Financial Performance (Million US$), 2011-2013
Table 9-19: Affymetrix - Key Gene Based Products
Table 9-20: Affymetrix - Financial Performance (Million US$), 2011-2013

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Global Next-generation Sequencing Trends

Global Next-generation Sequencing Trends

  • $ 12 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

An End-user Perspective The overall research objective was to capture and analyze global next-generation (NGS) sequencing trends and use. Most researchers outsource NGS technologies; however, in-house ...

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report discusses market growth, size and opportunities with respect to applications, geographic region and technologies. Forecast trends and revenue are given through 2019. Major players, ...

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

  • $ 6 650
  • Industry report
  • September 2014
  • by BCC Research

This BCC Research report provides an overview of the current state of the microRNA (miRNA) market, focusing mainly on continuing research endeavors, newly emerging sophisticated tools, reagents, techniques, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.